Arthritis

WD-40 is the stuff of legends, in at least two respects. There are the urban legends. If certain people are to be believed, WD-40 can cure arthritis, attract fish and dislodge snakes from...

VASTRA FROLUNDA, Sweden -- Artimplant continues to strengthen its market position. Since the beginning of 2012, Artimplant has taken over the sales of their products on the Nordic market. The former distributor, NMS,...

Investment to Support Commercialization of its Navigator[TM] Delivery System ALPHARETTA, Ga. -- Carticept Medical, Inc., a developer of innovative products for the treatment of cartilage injuries and osteoarthritis, today announced that it has...

Program Provides Individuals the Opportunity to Learn from Leading Lupus Experts WASHINGTON -- The Lupus Foundation of America (LFA) has announced its 2012 topics and dates for its nationwide education series, Lupus: Learn...

BERLIN -- JPT Peptide Technologies GmbH (JPT), a wholly-owned subsidiary of BioNTech AG (Mainz, Germany), IUCT and LEITAT (Barcelona, Spain) announced today their collaboration on the joint development of an enhanced anticancer therapy...

News this year are that the prize amount is doubled to totally SEK 8 million and that Video News Releases with experts from the prize committees, and newly recorded interviews with chosen Laureates...

CAMBRIDGE, Mass. -- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will announce its fourth quarter and full year 2011 financial results on Thursday, February 2, 2012 after the financial markets close. The company will host...

DUBLIN -- Research and Markets (http://www.researchandmarkets.com/research/f1260a/musculoskeletal_di) has announced the addition of the "Musculoskeletal Disorders Therapeutics Market to 2017 - Osteoarthritis Market to Decline with Patent Expiry of Celebrex in 2014" report to their...

DUBLIN -- Research and Markets (http://www.researchandmarkets.com/research/102d3b/the_top_50_europea) has announced the addition of the "The Top 50 European Manufacturers of Orthopaedic Implants" report to their offering. Did you know? * Approximately 8 out of 10...

ePharma Consumer ([R] ) Study Reveals New Trends around How Consumers Interact with Pharma, Including Customer Service Options, Patient Education, and Pharma Websites - Webinar January 25 at 2pm ET NEW YORK --...

Informing the Drug Development and Commercialization Industry CARY, N.C. -- Industry Standard Research (ISR) today announced the release of a new report focused on the impact comparative effectiveness research (CER) has and will...

Call it Lilly's squeeze play. Indianapolis-based Eli Lilly and Co. is now in the predicament of watching revenue fall as its patents on older products expire, even as the company needs to spend...

DUBLIN -- Research and Markets (http://www.researchandmarkets.com/research/9eaa07/evolution_in_the_p) has announced the addition of the "Evolution in the Pain Therapy Drugs Market: Nociceptive and Neuropathic Drug Development" report to their offering. "...Who are the players, and...

March of Dimes launches Bikers for Babies site providing 35,000 riders with online fundraising tools CHARLESTON, S.C. -- Blackbaud, Inc. (Nasdaq: BLKB) today announced that leading nonprofit organizations are using Blackbaud Friends Asking...

Not had time to read the journals? Let Dr Louise Newson bring you up to date on the latest research. - Bisphosphonates may be beneficial before knee and hip replacements BMJ 2011; 343:...

The Company licensed the technology for Australia & New Zealand for a one-time payment offer $700,000 and 12 1/2% Royalty Stream NEW YORK -- Intellicell Biosciences, Inc. (OTCQB: SVFC) (PINKSHEETS: SVFC); ("Intellicell") or...

BEDFORD, Mass. -- Anika Therapeutics, Inc. (Nasdaq: ANIK) a leader in products for tissue protection, healing and repair, based on hyaluronic acid ("HA") technology, today announced that Chief Financial Officer Kevin Quinlan will...

Painless, drug-free, elevated pressure device brings affordable, portable relief for pain and inflammation MIRAMAR BEACH, Fla. -- Baro-Therapies, Inc. has announced the national launch of The Rejuvenator, a portable barometric therapy device that...

-More than 25,000 people have started treatment for hepatitis C with INCIVEK([R]), positioning Vertex for continued growth, earnings and cashflow in 2012- -Preparations for approval and launch of KALYDECO(TM) ongoing; additional studies of...